Retail (non-accredited) investors generally cannot buy life settlements directly in the United States. Direct participation — owning a specific policy or a fractional interest in one — is legally restricted to accredited investors under SEC Rule 501 of Regulation D. Non-accredited investors can access indirect exposure through Regulation A+ Tier 2 offerings, certain publicly-traded alternative asset vehicles, and registered closed-end funds — but each pathway has meaningful trade-offs in liquidity, fees, and correlation with the underlying asset class. If you're not accredited and want exposure, understand what you're actually buying before committing capital.
I get this question constantly from people who've read about life settlement returns and want to participate, only to find out they don't qualify as accredited investors. Let me save you some research time: the short answer is no, not directly. But "no" isn't actually the end of the conversation. There are three or four indirect routes that technically exist, and I want to walk through each one honestly — including the ones I'd tell my own family to be careful with. The goal here isn't to sell you on any pathway; it's to help you understand what's actually available and what to watch for if you pursue any of them.
Why life settlements are restricted to accredited investors
Before I explain what retail investors can do, I want to be clear on why direct access is restricted in the first place. This isn't arbitrary regulation. The accredited investor framework exists because certain investments — life settlements included — carry characteristics that the SEC has determined make them unsuitable for investors without demonstrated financial sophistication or capacity to absorb losses. That framework traces back to Section 4(a)(2) of the Securities Act of 1933 and was codified in Regulation D starting in 1982.
For life settlements specifically, the restriction makes sense for three practical reasons. First, the asset is illiquid — you can't sell your interest on a public exchange if you need capital unexpectedly. Second, the return depends on an individual person's life expectancy, which introduces variance that's hard to diversify away in small positions. Third, the premium obligation continues for years after the initial purchase, which means an investor needs capacity to hold through the full term without being forced to liquidate at a bad price. Those three characteristics are what separate life settlements from typical retail-accessible investments like stocks or REITs.
The SEC Investor Bulletin on Life Settlements specifically cautions both institutional and retail-level investors about these risks, and notes that retail investors who do access life settlements through registered products often have to rely on intermediaries to assess the suitability of the transaction — which is exactly the kind of asymmetric-information situation that accredited rules are designed to prevent.
The net worth threshold (excluding primary residence) for individual accredited investor status under 17 CFR § 230.501. The threshold has not been indexed to inflation since 1982, which means a much larger portion of U.S. households qualify today than when the rule was first codified — though the SEC is actively reviewing the framework as part of its 2025–2026 regulatory agenda.
The 5 pathways retail investors actually have
Here are the five routes I've seen non-accredited retail investors take when they want some form of exposure to life settlements. I've labeled each one with my honest assessment — not because any of them are "bad" categorically, but because some fit most retail investors well and others really don't.
1. Regulation A+ Tier 2 offerings
Most accessibleRegulation A+ is an SEC exemption that allows companies to raise capital from both accredited and non-accredited investors with lighter disclosure requirements than a full IPO registration. Tier 2 offerings (up to $75M per year) are the pathway most commonly used for life-settlement-adjacent retail products. Under the rule, a non-accredited individual investor is limited to investing a maximum of 10% of the greater of their annual income or net worth per offering.
According to the SEC's Regulation A guidance, Tier 2 issuers must file audited financial statements and ongoing reports. This creates more transparency than fully private offerings — but it's still not the same as buying a registered mutual fund. Read the offering circular carefully, especially the redemption mechanics and the fee structure.
2. Publicly-traded alternative asset vehicles
Liquid but dilutedA small number of publicly-traded companies either invest in life settlements directly or operate life-settlement-related businesses. Buying their shares on a public exchange technically gives you indirect exposure to the asset class. The advantage is liquidity — you can enter and exit daily. The disadvantage is that you're buying a business, not the underlying asset. The share price of a public life-settlement-related company moves with broader equity market sentiment, not with the actuarial maturation of the underlying policies.
If your goal is the non-correlation benefit that makes life settlements interesting as an alternative asset, buying a public company that's correlated with equity markets defeats much of the purpose. This pathway is fine if you want to own a business operating in this space. It's not really a substitute for owning the asset itself.
3. Registered closed-end funds or interval funds
Structured retail accessInterval funds and some closed-end funds registered under the Investment Company Act of 1940 can hold life settlement portfolios and be sold to retail investors without accredited status requirements. These vehicles trade off daily liquidity for structured periodic repurchase windows (typically quarterly), which actually matches the underlying asset's illiquidity better than a daily-liquid fund would.
The SEC registration means more disclosure, more oversight, and a defined investor-protection framework. The trade-off is fee structure — interval funds carrying exotic assets like life settlements often have expense ratios meaningfully higher than plain-vanilla mutual funds. Read the prospectus carefully, compare gross and net expense ratios, and look at the fund's track record of meeting its repurchase obligations.
4. Pension and retirement plan allocations
Indirect and limitedMany pension funds, endowments, and larger institutional retirement plans allocate a portion of their alternatives sleeve to life settlements. If you're a beneficiary of such a plan, you may already have indirect exposure to the asset class without realizing it. This isn't really a pathway you can actively use — it's just worth knowing that large institutional retirement structures often include life settlements as part of their alternatives book because the return profile and non-correlation characteristics fit well with long-dated liabilities.
For the average retail investor with a self-directed 401(k) or IRA, this pathway generally isn't actionable. Some self-directed IRA custodians technically allow life settlement holdings, but that path requires you to qualify as accredited through the IRA entity framework, which loops back to the original restriction.
5. Unregistered "opportunity" offerings
High fraud riskThis is the category I want to flag hardest. Over the years, I've seen multiple "life settlement investment opportunities" marketed directly to retail investors — usually through high-commission intermediaries, affinity marketing, or online pitch decks promising 20%+ returns with low minimums. Many of these have ended in SEC enforcement actions, investor losses, or both. The SEC Office of Investor Education and Advocacy has issued multiple warnings about this exact category of offering.
The pattern is consistent: an issuer structures the offering to claim exemption from SEC registration, markets aggressively to non-accredited retail investors, and either fails operationally or becomes the subject of enforcement. If someone is pitching you a "life settlement investment" with no accreditation check, no PPM or offering circular to review, and pressure to invest quickly — walk away and consider reporting the offering to the SEC.
Skip the workarounds — access the real asset
HYV's marketplace is built for accredited investors who want direct ownership or fractional interest in individual vetted policies. Full documentation, no pooled dilution, no public-market correlation.
Browse Investor OpportunitiesA closer look at Regulation A+ offerings
Of the five pathways above, Regulation A+ Tier 2 is the one that gets the most attention — and the one most likely to show up in an investor's inbox as a "life settlement opportunity for retail investors." It deserves its own section because the details matter a lot for whether any specific Reg A+ life settlement offering is actually a good fit for you.
How Regulation A+ Tier 2 works
Under SEC Regulation A, issuers can raise up to $75M per year from both accredited and non-accredited investors without full IPO registration. Tier 2 specifically imposes these requirements that retail investors should verify:
| Requirement | What it means for you |
|---|---|
| Audited financial statements | Verified by an independent PCAOB-registered auditor |
| Offering circular filed with SEC | Public disclosure of risks, structure, use of funds |
| Ongoing reporting | Annual, semiannual, and current reports similar to public companies |
| 10% non-accredited investment cap | Max 10% of your greater of income or net worth per offering |
| State preemption | No separate state blue-sky qualification required |
What to verify before committing
If you're looking at a specific Reg A+ life settlement offering, these are the questions I'd want answered before committing capital:
- Is the offering current and qualified? Search the SEC's EDGAR database for the issuer. Reg A+ offerings must be qualified before the issuer can accept money — a "coming soon" pitch isn't an active offering.
- What is the underlying asset structure? Are you buying interests in actual life insurance policies, or are you buying interests in a company that invests in policies? The distinction affects your legal position in bankruptcy or dispute scenarios.
- What's the total expense load? Reg A+ structures often carry higher upfront fees than institutional-facing alternatives. Add up all the fees — organizational, management, servicing, platform — and calculate the net return you'd need.
- What's the redemption mechanism? Is there a defined exit? Some Reg A+ offerings have no secondary market at all. If you need capital back, you may have no way to get it other than waiting for the offering to wind down.
- Who are the sponsors and what's their track record? Look up the principals on FINRA BrokerCheck and the SEC Action Lookup. Any regulatory history is worth knowing before committing capital.
The SEC's EDGAR system at sec.gov/edgar/searchedgar/companysearch lets you search any issuer's filings. Look for Form 1-A (offering statement), any post-qualification amendments, and Form 1-K and 1-SA ongoing reports. If the issuer hasn't filed ongoing reports on time, that's a signal worth taking seriously. FINRA BrokerCheck and the SEC Action Lookup tool are complementary — use both.
What it takes to become accredited
If after all of this you've decided the best path is to actually qualify as accredited and access the asset directly, here's the short version of what that looks like. Under 17 CFR § 230.501 (Rule 501 of Regulation D), there are three individual pathways to accredited status:
- Income pathway: Annual income of $200,000 individually, or $300,000 jointly with a spouse or partner, in each of the two most recent calendar years, with a reasonable expectation of maintaining that income level in the current year.
- Net worth pathway: Individual or joint net worth exceeding $1 million, excluding your primary residence. This is the most common pathway for early-career professionals with significant investment portfolios but lumpier income.
- Professional credentials pathway: Holding an active Series 7, Series 65, or Series 82 license in good standing. Added to the rule in 2020, this creates a pathway for financial services professionals who don't yet meet the dollar thresholds but have demonstrated financial sophistication.
The SEC has signaled in its 2025–2026 regulatory agenda that it's considering expanding the credentials pathway. That's worth watching if you're a financial professional or someone pursuing relevant certifications, but nothing has been finalized as of this writing.
See active policies on the HYV platform
Skip the retail pathways that don't quite work. If you qualify as accredited, you can access direct ownership and fractional interests in individual vetted policies with full documentation.
Red flags when a retail "life settlement" product looks too easy
After more than a decade in this industry, these are the patterns I've seen that reliably precede problems. If any of these show up in a pitch directed at retail investors, I'd treat it as a strong signal to pause.
- No accreditation verification and no Reg A+ qualification. If the offering isn't registered and isn't qualified under Reg A+, but is still being marketed to non-accredited investors, that's an irregular situation. Ask the sponsor which exemption they're relying on — and verify it.
- Promises of specific annual returns. Life settlements have historical return averages, but any offering that guarantees a specific rate of return is either misrepresenting the product or structuring it in a way that pushes risk onto some other party. The SEC investor bulletin specifically warns about "life expectancy guarantee" structures that purport to backstop returns.
- Unusual compensation structures for the salesperson. If the person pitching you the investment is earning 10–15% upfront commission, that's not aligned with your interests. High-commission products aren't inherently fraudulent, but the economics push the salesperson toward selling rather than advising.
- Pressure to commit within days. Legitimate investment opportunities — Reg A+, interval funds, anything registered — have extended offering periods by design. The "must close by Friday" pressure is a tell.
- Thinly documented issuer. Any credible offering has audited financial statements, a PPM or offering circular, and a clear organizational structure you can research. If the marketing material is a slick 10-page PDF and nothing else, you don't have enough to evaluate the investment.
Talk to someone about your actual situation
If you're accredited and want to deploy capital, see what's available on the HYV platform. If you're not yet accredited and want to understand your options, we can walk through what makes sense without selling you something that doesn't fit.
Frequently asked questions
Can a non-accredited investor buy a life settlement directly?
No. Direct ownership of a life settlement policy or a fractional interest in one is restricted to accredited investors under SEC Rule 501 of Regulation D. The SEC has consistently treated life settlement investments as securities that require either accredited investor participation or registration/qualification under a separate exemption. A non-accredited investor cannot sign a purchase agreement for a specific policy or participate in a private placement of fractional interests.
Are life settlement ETFs available for retail investors?
There is no dedicated life settlement ETF listed on major U.S. exchanges as of this writing. Some broadly-diversified alternative asset ETFs may have small allocations to life settlement-adjacent exposure through their holdings of publicly-traded specialty finance companies, but this is not direct exposure to the underlying asset. If an ETF explicitly claiming "life settlement" exposure appears in the market, read the prospectus carefully to understand what the fund actually holds — "exposure" can mean many different things.
How much can a non-accredited investor commit to a Regulation A+ offering?
Under Regulation A+ Tier 2, a non-accredited individual investor is limited to investing a maximum of 10% of the greater of their annual income or net worth per offering. The investor self-certifies this limitation to the issuer. Accredited investors participating in the same offering are not subject to the 10% cap. Issuers are required to verify the representation but generally do so through investor self-certification rather than independent verification, so the compliance burden sits with the individual investor to represent accurately.
What's the difference between an interval fund and a Regulation A+ life settlement offering?
An interval fund is a registered investment company under the Investment Company Act of 1940 with specific structural requirements — defined repurchase windows, SEC oversight of the fund sponsor and advisor, and ongoing regulatory reporting as a registered fund. A Regulation A+ offering is an exempt offering by an individual issuer that sells securities directly to investors. Interval funds have more investor protections structurally, but both can legally be sold to non-accredited retail investors. The choice between them depends on whether you want the protections of a registered fund framework or are comfortable with a more concentrated Reg A+ issuer exposure.
If I'm close to accredited, should I wait to qualify or invest through a retail pathway now?
This is a personal financial decision that depends on your broader situation and timeline, and I'd genuinely recommend talking to a qualified financial advisor rather than making this call from a blog article. But here's the directional framework I'd use: if you're within 12–24 months of qualifying under the net worth or income pathway, waiting is often worth it because direct ownership and fractional interests typically offer better fee structures and more control than retail-accessible alternatives. If you're 3+ years out from qualifying, the retail pathways may make more sense to start building exposure — just be deliberate about which pathway you choose and what trade-offs you're accepting.
Can I use a self-directed IRA to invest in life settlements as a non-accredited investor?
Some self-directed IRA custodians technically allow life settlement holdings, but the IRA itself generally needs to qualify as an accredited investor under the entity pathway of Rule 501(a)(8), which requires $5M+ in assets under the entity's control or all equity owners to be accredited. For most retail investors, a self-directed IRA does not create a workaround to the accredited requirement. There are also complex tax considerations with life settlements held in tax-advantaged accounts — consult a CPA and a securities attorney before pursuing this path.
Do SEC changes to the accredited investor definition affect retail access?
Potentially, yes. The SEC expanded the accredited investor definition in 2020 by adding the professional credentials pathway (Series 7, 65, and 82 licenses). The Commission has indicated in its 2025–2026 regulatory agenda that it is reviewing further expansions, which could include additional professional certifications or alternative sophistication criteria. Congress has also considered legislation creating formal certification tests to qualify as accredited. None of these changes are finalized as of this writing. For now, the three pathways in Rule 501 remain the operative framework.
